Request Demo
Last update 07 Feb 2025
Naltrexone/Acetaminophen
Last update 07 Feb 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms ALLOD-2 |
Target |
Mechanism COX inhibitors(Cyclooxygenases inhibitors), Opioid receptors antagonists(Opioid receptors antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure/Sequence
Molecular FormulaC20H24ClNO4 |
InChIKeyRHBRMCOKKKZVRY-ITLPAZOVSA-N |
CAS Registry16676-29-2 |
View All Structures (2)
Related
3
Clinical Trials associated with Naltrexone/AcetaminophenNCT03194555
Randomized, Double-Blind, Study to Assess Low-Dose Naltrexone and Acetaminophen Combination in the Prevention of Episodic Migraine in Adults
NCT03201393
A Single Site, Phase 2B, Randomized, Double-Blind, Study to Assess the Efficacy, Safety, and Tolerability of Low-Dose Naltrexone and Acetaminophen Combination vs. Placebo in the Treatment of Chronic Low Back Pain (ANODYNE-4)
NCT03061734
A Clinical Trial to Assess a Single Dose of Low-Dose Naltrexone and Acetaminophen Combination and Its Components in the Acute Treatment of Migraine
100 Clinical Results associated with Naltrexone/Acetaminophen
Login to view more data
100 Translational Medicine associated with Naltrexone/Acetaminophen
Login to view more data
100 Patents (Medical) associated with Naltrexone/Acetaminophen
Login to view more data
100 Deals associated with Naltrexone/Acetaminophen
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Low Back Pain | Phase 2 | US | 15 Aug 2017 | |
| Migraine Disorders | Phase 2 | US | 18 Feb 2017 | |
| Adjustment disorders | Phase 1 | - | - |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Phase 2 | 12 | (Low-Dose Naltrexone and Acetaminophen Combination) | flgjmgzxtq(wfmdmzphbf) = eebeuapntp oxcnfwuton (jgsoupkcyw, dgutnyvfow - egzgrgkmzj) View more | - | 10 Apr 2024 | ||
Placebo (Placebo) | flgjmgzxtq(wfmdmzphbf) = lojunokczh oxcnfwuton (jgsoupkcyw, qciakotshb - azujvfybvn) View more |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free